National Family Caregivers Month
"Every day, family caregivers across our Nation are caring for loved ones who are aging, chronically ill, or disabled. Through their selfless actions, they bring comfort to those in need, enrich their own lives, and reflect the true spirit of America." So begins the proclamation that US President George W. Bush signed November 4th declaring the month National Family Caregivers Month.
Every seriously ill person needs one or more caregivers to help deal with medical problems and day-to-day tasks. Spouses, parents, children, loved ones, friends and more. We cheer you all.
Caregiver Information
- The Caregiver's Essential Handbook
- Caregiver Magazine
- The Caregivers Online Support Group/Mailing List
- National Family Caregivers Association
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
